WallStreetZen

NASDAQ: SNY
Sanofi Earnings & Revenue

SNY past earnings growth

How has SNY's earnings growth performed historically?
Company
375.99%
Industry
13.35%
Market
37.79%
SNY's earnings have grown faster (27.45% per year) than the US Drug Manufacturers - General industry average (4.06%)
Performance
SNY's earnings have grown faster (27.45% per year) than the US market average (19.73%)
Performance
SNY's earnings growth is accelerating - its growth over the last year (375.99%) is above its 5-year compound annual rate (27.45%)
Performance

SNY past revenue growth

How has SNY's revenue growth performed historically?
Company
7.78%
Industry
12.11%
Market
20.26%
SNY's revenue has grown slower (3.78% per year) than the US Drug Manufacturers - General industry average (5.94%)
Performance
SNY's revenue has grown slower (3.78% per year) than the US market average (18.37%)
Performance
SNY's revenue growth is accelerating - its growth over the last year (7.78%) is above its 5-year compound annual rate (3.78%)
Performance

SNY earnings and revenue history

Current Revenue
$45.6B
Current Earnings
$15.0B
Current Profit Margin
33%
SNY's has demonstrated consistent long-term earnings growth over the past 10 years (113.78%)
Performance

SNY Return on equity

Current Company
20.2%
Current Industry
35.6%
Current Market
49.8%
SNY's Return on Equity (20.2%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

SNY Return on assets

Current Company
10.8%
Current Industry
6.9%
Current Market
5.4%
SNY is generating higher Return on Assets (10.8%) than the US Drug Manufacturers - General industry average (7.12%)
Performance

SNY Return on capital employed

Current Company
15.24%
Current Industry
11.1%
SNY has gotten more efficient at generating Return on Capital (15.24%) compared to 3 years ago (12.52%)
Performance

Sanofi Earnings & Revenue FAQ

What was SNY's earnings growth in the past year?

As of Q2 2021, Sanofi's earnings has grown 375.99% year over year. This is 362.64 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 13.35%. Sanofi's earnings in the past year totalled $15.02 billion.

What was SNY's revenue growth in the past year?

As of Q2 2021, Sanofi's revenue has grown 7.78% year over year. This is 4.33 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.11%. Sanofi's revenue in the past year totalled $45.57 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.